Athira Pharma Slashes Workforce by 70%, Shifts Focus Amid Failed Trial Results
In a recent announcement, Athira Pharma plans to slash its workforce by 70%, focusing solely on ATH-1105 for neurodegenerative...
neurodegenerative diseases
FDA Fast-Track Designation for AC Immune’s Neurodegenerative Disease Diagnostic Scan
In a breakthrough announcement, AC Immune reveals its partner Life Molecular Imaging has received fast-track designation from the FDA...
Evotec Secures $25M from Bristol Myers Squibb Partnership for Neuroscience Research
In a major development, Evotec receives a $25 million milestone payment from Bristol Myers Squibb due to their successful...
Sangamo and Genentech Team Up to Tackle Neurodegenerative Diseases with Innovative Genomic Medicines
In a groundbreaking move for neurodegenerative disease treatment, Sangamo Therapeutics partners with Genentech to develop innovative genomic medicines. This...
Moderna Co-Founder Pivots to AI-Driven Drug Discovery with New Venture
In a groundbreaking discovery, scientists have found evidence of water on the moon's sunlit surface. This revelation challenges previous...
Preventing Dementia: 3 Key Factors to Consider
Lead: Worried about dementia as you age? Discover how lifestyle choices can help keep your mind sharp and prevent...
Aprinoia Therapeutics Files for IPO, Offering 2 Million Shares
Lead: Aprinoia Therapeutics, a clinical stage biotech company specializing in neurodegenerative diseases, is making waves with its initial public...
Aprinoia Therapeutics Files for IPO to Develop Neurodegenerative Disease Solutions
Clinical-stage biotech company Aprinoia Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The...
NeuroSense Therapeutics Reports Positive Safety Data in Phase 2 Trial for ALS Treatment
Shares of NeuroSense Therapeutics dropped after the company announced that its ALS treatment trials met primary safety and tolerability...
Merck to Acquire Caraway Therapeutics for $610 Million
Merck & Co. Inc. has announced its acquisition of Caraway Therapeutics for up to $610 million. Caraway Therapeutics is...